0001420108-26-000002.txt : 20260707 0001420108-26-000002.hdr.sgml : 20260707 20260707140903 ACCESSION NUMBER: 0001420108-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260707 DATE AS OF CHANGE: 20260707 EFFECTIVENESS DATE: 20260707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glucose Health, Inc. CENTRAL INDEX KEY: 0001420108 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 901117742 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-589791 FILM NUMBER: 261158925 BUSINESS ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 BUSINESS PHONE: 479-802-3827 MAIL ADDRESS: STREET 1: 609 SW 8TH STREET, SUITE 600 CITY: BENTONVILLE STATE: AR ZIP: 72712 FORMER COMPANY: FORMER CONFORMED NAME: Bio-Solutions Corp. DATE OF NAME CHANGE: 20071203 D 1 primary_doc.xml X0708 D LIVE 0001420108 Glucose Health, Inc. 609 SW 8TH STREET, SUITE 600 BENTONVILLE AR ARKANSAS 72712 479-802-3827 DELAWARE Bio-Solutions Corp. Corporation true Mark Schaftlein 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director CEO and Director of Issuer Marc Hatch 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Chief Operating Officer and Chief Financial Officer of Issuer Chris Jemapete 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Edmund Burke 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Manufacturing $1 - $1,000,000 06b false 2026-06-25 false true true true Investment Units. Each Unit consists of one share of common stock and warrant to purchase one share of common stock 0ver 5 year term at $0.60 per shares false 60000 120000 60000 60000 false 1 0 0 0 true false Glucose Health, Inc. /s/ Mark Schaftlein Mark Schaftlein CEO 2026-07-07